Yongdi Zuo
Overview
Explore the profile of Yongdi Zuo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
46
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen L, Zuo Y, He M, Duo L, Tang W
J Int Med Res
. 2024 Aug;
52(8):3000605241272639.
PMID: 39216017
Objective: Sodium-glucose cotransporter 2 inhibitors (SGLT2i) target the reabsorption of sodium and glucose in the kidney proximal tubules to reduce blood sugar levels. However, clinical randomized controlled trials on SGLT2i...
2.
Duo L, Chen L, Zuo Y, Guo J, He M, Zhao H, et al.
Int Immunopharmacol
. 2023 Nov;
125(Pt A):111126.
PMID: 37913570
Background: Idiopathic membranous nephropathy (IMN) is a type of nephrotic syndrome and the leading cause of chronic kidney disease. As far as we know, no predictive model for assessing the...
3.
Kang Y, Zuo Y, He M, Duo L, Chen X, Tang W
Int Immunopharmacol
. 2022 Jun;
110:108966.
PMID: 35764016
Background: Lupus nephritis (LN) is a major organ complication and cause of morbidity and mortality in patients with systemic lupus erythematosus. This study aims to provide the clinician with a...
4.
He M, Li C, Kang Y, Zuo Y, Duo L, Tang W
Int Immunopharmacol
. 2021 Nov;
101(Pt B):108341.
PMID: 34775367
Purpose: Early remission of Immunoglobulin A vasculitis nephritis (IgAVN) substantially affects its prognosis. In this work, a multivariate model to predict the 1-year remission probability of patients with IgAVN was...
5.
He M, Li C, Tang W, Kang Y, Zuo Y, Wang Y
Immun Inflamm Dis
. 2021 Sep;
9(4):1529-1540.
PMID: 34469062
Background: Recent studies reported the responses of ustekinumab (UST) for the treatment of Crohn's disease (CD) differ among patients, while the cause was unrevealed. The study aimed to develop a...
6.
Cao Y, Mi X, Zhang D, Wang Z, Zuo Y, Tang W
Clin Sci (Lond)
. 2020 Jan;
134(2):139-154.
PMID: 31930399
Acute kidney injury (AKI) is a common serious syndrome characterized by rapid decrease of glomerular filtration rate and the progressive increase of serum creatinine. Circular RNAs (circRNAs) are regulatory RNAs...
7.
Identification of prognosis-related alternative splicing events in kidney renal clear cell carcinoma
Zuo Y, Zhang L, Tang W, Tang W
J Cell Mol Med
. 2019 Sep;
23(11):7762-7772.
PMID: 31489763
Alternative splicing (AS) contributes to protein diversity by modifying most gene transcriptions. Cancer generation and progression are associated with specific splicing events. However, AS signature in kidney renal clear cell...
8.
Zhang D, Cao Y, Zuo Y, Wang Z, Mi X, Tang W
Exp Ther Med
. 2019 Jul;
18(2):1235-1245.
PMID: 31316619
Immunoglobulin A (IgA) nephropathy (IgAN) is the most common glomerular disease. The major pathological changes associated with it affect cell proliferation, fibrosis, apoptosis, inflammation and extracellular matrix (ECM) organization. However,...